1. Home
  2. HCWB vs UGRO Comparison

HCWB vs UGRO Comparison

Compare HCWB & UGRO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo HCW Biologics Inc.

HCWB

HCW Biologics Inc.

HOLD

Current Price

$0.58

Market Cap

3.7M

Sector

Health Care

ML Signal

HOLD

Logo urban-gro Inc.

UGRO

urban-gro Inc.

HOLD

Current Price

$2.35

Market Cap

2.5M

ML Signal

HOLD

Company Overview

Basic Information
Metric
HCWB
UGRO
Founded
2018
2014
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Industrial Specialties
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
3.7M
2.5M
IPO Year
2021
2018

Fundamental Metrics

Financial Performance
Metric
HCWB
UGRO
Price
$0.58
$2.35
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
1
Target Price
$35.00
$75.00
AVG Volume (30 Days)
79.9K
336.3K
Earning Date
01-01-0001
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$4,099,750.00
$40,008,850.00
Revenue This Year
N/A
$98.41
Revenue Next Year
N/A
$23.34
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.22
$0.11
52 Week High
$17.80
$4.50

Technical Indicators

Market Signals
Indicator
HCWB
UGRO
Relative Strength Index (RSI) 22.99 60.16
Support Level N/A $0.28
Resistance Level $1.35 $4.50
Average True Range (ATR) 0.10 0.46
MACD -0.01 -0.08
Stochastic Oscillator 5.02 18.55

Price Performance

Historical Comparison
HCWB
UGRO

About HCWB HCW Biologics Inc.

HCW Biologics Inc is a clinical-stage biopharmaceutical company focused on discovering and developing novel immunotherapies to lengthen the health span by disrupting the link between chronic, low-grade inflammation and age-related diseases. The company has developed TOBI discovery platform, or Tissue factor-based fusion discovery platform, for the design of category-defining immunotherapeutic drugs. It has selected two molecules as its product candidate; HCW9218 and HCW9302. HCW9218 is a bifunctional immunotherapeutic designed with the capabilities to neutralize transforming growth and stimulate immune cells. HCW9302 is designed to activate and expand regulatory T cells, which deactivate inflammasomes.

About UGRO urban-gro Inc.

Urban-gro Inc operated as an integrated professional services and design-build firm offering architectural, engineering, and construction management solutions to the CEA, industrial, healthcare, and other commercial sectors. The company generated revenue by billing employees time on client projects and provided architectural, engineering, systems procurement and integration, and construction design-build solutions with a single point of accountability. For CEA clients, it developed indoor cultivation facilities for specialty crops, including cannabis and produce such as leafy greens, vegetables, herbs, and berries. Its segments included Equipment Systems (commercial horticulture equipment), Services (design-build services), and Construction Design-Build (general contracting).

Share on Social Networks: